DOJ Reports $3.7B Haul in FY 2017 FCA Recoveries
Client Alert | 1 min read | 12.26.17
On December 21, 2017, the Department of Justice reported that it recovered more than $3.7 billion in settlements and judgments from civil False Claims Act (FCA) cases in Fiscal Year 2017. The FY 2017 recovery is the fourth largest total in thirty years. At the industry level, DOJ reported $2.47B in recoveries from the health care sector, $220M from defense companies, and approximately $1B from the remaining industries such as banking, higher education, and energy.
The change in presidential administration appears to have had little effect on FCA activity. The number of new FCA actions in FY 2017 remained high with relators bringing 674 new qui tam matters and DOJ initiating 125 matters on its own. These numbers are consistent with the prior five years and suggests that FCA will remain an active area for investigations and litigation in 2018.
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
